Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney diseaseLaTonya J. Hickson, James L. Kirkland, Larissa Prata et al.|EBioMedicine|2019Cited by 1.3k
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart AssociationRobert M. Carey, William B. White, Brent M. Egan et al.|Hypertension|2018Cited by 1.1k
Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456LaTonya J. Hickson, James L. Kirkland, Larissa Prata et al.|EBioMedicine|2020Cited by 59